Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nauck

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1996
Therapeutic potential of glucagon-like peptide 1 in type 2 diabetesM Nauck
MMW Fortschritte Der Medizin|June 3, 2010
[Diabetes treatment of the move. Prevent cardiovascular catastrophe from the start]M Nauck
Deutsche Medizinische Wochenschrift (1946)|April 29, 2010
[Obesity and diabetes mellitus: increasing problems call for increasing efforts]M Nauck
Diabetologia|November 19, 2009
Dualities of interest are not restricted to financial ties to the pharmaceutical industryM Nauck
Clinical Chemistry and Laboratory Medicine|October 11, 2001
Pre-analytical conditions affecting the determination of the plasma homocysteine concentrationM Nauck, E Bisse, M Nauck, et al.
Diabetes, Obesity & Metabolism|October 23, 2015
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitorsM Nauck
Der Internist|May 24, 2001
[Antidiabetic combination therapy]M Nauck
Deutsche Medizinische Wochenschrift (1946)|April 25, 2013
[Early insulin treatment in type 2 diabetes--no]M Nauck
Diabetes/Metabolism Reviews|July 1, 1992
Gut hormones and diabetes mellitusW Creutzfeldt, M Nauck
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1977
[Demonstration of microcoagulation in the pulmonary circulation]N Kleine, M Nauck
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1996
Therapeutic potential of glucagon-like peptide 1 in type 2 diabetesM Nauck
MMW Fortschritte Der Medizin|June 3, 2010
[Diabetes treatment of the move. Prevent cardiovascular catastrophe from the start]M Nauck
Deutsche Medizinische Wochenschrift (1946)|April 29, 2010
[Obesity and diabetes mellitus: increasing problems call for increasing efforts]M Nauck
Diabetologia|November 19, 2009
Dualities of interest are not restricted to financial ties to the pharmaceutical industryM Nauck
Clinical Chemistry and Laboratory Medicine|October 11, 2001
Pre-analytical conditions affecting the determination of the plasma homocysteine concentrationM Nauck, E Bisse, M Nauck, et al.
Diabetes, Obesity & Metabolism|October 23, 2015
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitorsM Nauck
Der Internist|May 24, 2001
[Antidiabetic combination therapy]M Nauck
Deutsche Medizinische Wochenschrift (1946)|April 25, 2013
[Early insulin treatment in type 2 diabetes--no]M Nauck
Diabetes/Metabolism Reviews|July 1, 1992
Gut hormones and diabetes mellitusW Creutzfeldt, M Nauck
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1977
[Demonstration of microcoagulation in the pulmonary circulation]N Kleine, M Nauck
Pageof 17